Japan Stocks Slump, China Stimulus Soars | Asian Markets Update

By By Rediff Money Desk, Hong Kong
Sep 30, 2024 10:42
Asian markets saw a wild start to the week, with Tokyo's Nikkei 225 index tumbling nearly 5% while Chinese markets soared on news of fresh stimulus for the faltering economy. Learn more about the reasons behind the market fluctuations.
Hong Kong, Sep 30 (AP) Asian markets had a wild start to the week, with Tokyo's Nikkei 225 index tumbling nearly 5 per cent while Chinese markets soared on news of fresh stimulus for the faltering economy.

Japanese shares sank after the ruling Liberal Democrats chose former Defence Minister Shigeru Ishiba to succeed Prime Minister Fumio Kishida, who is due to step down on Tuesday.

Ishiba has expressed support for the Bank of Japan's moves to raise interest rates from their near-zero level. He also backs other policies, such as possibly raising corporate taxes, that are seen as less market friendly than his chief rival for the top job, Economic Security Minister Sanae Takaichi, who he beat in a run-off vote late Friday.

The Nikkei was trading down 4.7 per cent at 37,956.32 by midday Monday.

The dollar fell from over 146 yen to under 143 yen after the ruling party's vote ended late Friday. By mid-Monday, it was trading at 142.49 yen, up from 142.29.

Exporters' shares plunged, since a stronger yen is a disadvantage for Japanese companies that make a large share of their sales and profits overseas.

Toyota Motor Corp. dropped 3.5 per cent. Honda Motor Co.'s shares fell 4.1 per cent and Nissan Motor Co.'s declined 5.8 per cent.

Ishiba has said he backs Kishida's “new capitalism” policies, which ostensibly would foster more equal distribution of national wealth. But sharply rising prices have undermined progress toward encouraging consumers to spend more.

Meanwhile, the Hang Seng in Hong Kong jumped 3.3 per cent to 21,321.97, with Hong Kong's Hang Seng Mainland Properties Index up 8.6 per cent. The Shanghai Composite index surged 5.7 per cent to 3,263.59.

The rallies were auspiciously timed, coming on the eve of a week-long national holiday marking 75 years of communist rule in China. Markets in mainland China will be closed Tuesday through October 7.

China is moving forward with measures announced last week to support the property industry and revive languishing financial markets. The central bank announced on Sunday that it would direct banks to cut mortgage rates for existing home loans by October 31. Meanwhile, the major southern city of Guangzhou lifted all home purchase restrictions over the weekend, while both Shanghai and Shenzhen revealed plans to ease key buying curbs.

The effort to wrest the housing market out of a prolonged downturn comes as the economy shows signs of slowing further. China's manufacturing activity in September contracted for a fifth consecutive month, as the official purchasing managers' index came in at 49.8, remaining below the 50 line that separates expansion from contraction, according to data from the National Bureau of Statistics released on Monday.

Elsewhere in Asia, Australia's S&P/ASX 200 advanced 0.7 per cent to 8,273.10. South Korea's Kospi dropped 0.9 per cent to 2,627.13.

On Friday, the S&P 500 edged down by 0.1 per cent from its all-time high to 5,738.17. The Dow Jones Industrial Average rose 0.3 per cent to 42,313.00, setting its own record, while the Nasdaq composite slipped 0.4 per cent to 18,119.59.

Treasury yields eased in the bond market after a report showed inflation slowed in August by a bit more than economists expected. It echoed similar numbers from earlier in the month about inflation, but Friday's report has resonance because it's the measure that officials at the Federal Reserve prefer to use.

The Fed kept its main interest rate at a two-decade high for more than a year, in hopes of slowing the economy enough to drive inflation toward its 2 per cent target. Now that inflation has eased substantially from its peak two summers ago, the Fed has begun cutting rates to ease conditions for the slowing job market and prevent a recession.

The risk of a downturn remains and US employers have slowed their hiring. A inflation report on Friday showed growth in US consumer spending in August fell shy of economists' expectations.

In other dealings Monday, benchmark US crude oil added 40 cents to USD 68.58 per barrel. Brent crude, the international standard, rose 45 cents at USD 71.99 per barrel.

The euro was trading at USD 1.1158, down from USD 1.1163. (AP)

Source: Associated Press
Read More On:
inflationasian marketsbrent crudeinterest ratesmanufacturing activitynikkei 225euromortgage ratesshanghai compositeproperty industryhang sengeconomic securityfumio kishidachina stimulusjapan stocksshigeru ishibaus crude oil
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

Sony India Grows 21% in 2023-24, Bets Big on...

Sony India reports 21% growth in 2023-24, driven by premium TV segment. Company expects...

UST Expands India Footprint with New Kochi Campus

UST, a digital transformation solutions company, is expanding its presence in India...

Govt Urges White Goods Industry to Apply for...

India's DPIIT urges white goods manufacturers to apply for fiscal benefits under...

ICAI Launches Stress Management Initiatives for...

ICAI sets up a stress management group and counselling help desk following the death of...

Greenzo Energy Wins Rs 1,200 Cr Hydrogen...

Greenzo Energy has secured a multi-crore hydrogen project from TANGEDCO, taking its...

L&T Wins Energy Management System Order...

Larsen & Toubro has secured an order to develop and implement energy management...

Dr Agarwal's Healthcare IPO: Rs 3,000 Crore Eye...

Dr Agarwal's Healthcare, backed by Temasek and TPG, files IPO papers to raise Rs...

India's Consumer Durables Market: 4th Largest...

India's consumer durables market is poised to become the world's 4th largest by 2027,...

Venus Remedies Secures Cancer Drug Approvals in...

Venus Remedies has obtained marketing authorisations for carboplatin and bortezomib in...

Manba Finance Shares Debut with 25% Premium

Manba Finance shares listed at Rs 150 on the BSE, a 25% premium over the issue price....

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com